These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6105163)

  • 1. Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography: II. A further five beta blockers and dihydralazine.
    Jack DB; Dean S; Kendall MJ; Laugher S
    J Chromatogr; 1980 Aug; 196(1):189-92. PubMed ID: 6105163
    [No Abstract]   [Full Text] [Related]  

  • 2. Thermospray liquid chromatography/mass spectrometry of polar beta-blocking drugs: preliminary results.
    Leloux MS; Niessen WM; van der Hoeven RA
    Biol Mass Spectrom; 1991 Oct; 20(10):647-9. PubMed ID: 1686558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography. Five commonly used beta blockers and hydralazine.
    Jack DB; Dean S; Kendall MJ
    J Chromatogr; 1980 Jan; 187(1):277-80. PubMed ID: 6102096
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of some beta adrenergic blocking drugs and their metabolites in urine by thin layer chromatography.
    Bonicamp JM; Pryor L
    J Anal Toxicol; 1985; 9(4):180-2. PubMed ID: 2863421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of blockers of adrenergic beta-receptors by thin layer chromatography].
    Nováková E
    Soud Lek; 2006 Jan; 51(1):9-15. PubMed ID: 16506605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of atenolol, sotalol and labetalol on muscle blood flow in man.
    Raman GV; Mwongera FM; Warren DJ
    Postgrad Med J; 1986 Sep; 62(731):841-4. PubMed ID: 2880341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labetalol is metabolized oxidatively in humans.
    Gal J; Zirrolli JA; Lichtenstein PS
    Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):3-17. PubMed ID: 3205978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The feasibility of the detection and quantitation of beta-adrenergic blockers by solid-phase extraction and subsequent derivatization with methaneboronic acid.
    Branum GD; Sweeney S; Palmeri A; Haines L; Huber C
    J Anal Toxicol; 1998; 22(2):135-41. PubMed ID: 9547410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
    Lund-Johansen P
    Eur Heart J; 1983 Jul; 4 Suppl D():1-12. PubMed ID: 6137366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the analysis of beta-blockers by different techniques.
    Pujos E; Cren-Olivé C; Paisse O; Flament-Waton MM; Grenier-Loustalot MF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):4007-14. PubMed ID: 19879818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetalol analysis with the TOXI-LAB. A Drug-Detection system.
    Martel PA; Adams D; Jones DW; O'Donnell CM
    Clin Chem; 1986 May; 32(5):915. PubMed ID: 3698301
    [No Abstract]   [Full Text] [Related]  

  • 12. Thin-layer chromatographic analysis of some beta-blocking drugs in plasma.
    Witek A; Przyborowski L
    Acta Pol Pharm; 1997; 54(3):183-6. PubMed ID: 9511444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of the beta-blocker atenolol and several complementary antihypertensive agents in pharmaceutical formulations and urine by capillary zone electrophoresis.
    Maguregui MI; Jiménez RM; Alonso RM
    J Chromatogr Sci; 1998 Oct; 36(10):516-22. PubMed ID: 9789982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct enantioseparation of some beta-adrenergic blocking agents using impregnated thin-layer chromatography.
    Bhushan R; Thiongo GT
    J Chromatogr B Biomed Sci Appl; 1998 Apr; 708(1-2):330-4. PubMed ID: 9653983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorimetric determination of atenolol in plasma and urine by direct evaluation of thin-layer chromatograms.
    Schäfer M; Mutschler E
    J Chromatogr; 1979 Feb; 169():477-81. PubMed ID: 536437
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioassay, determination and separation of enantiomers of atenolol by direct and indirect approaches using liquid chromatography: A review.
    Batra S; Bhushan R
    Biomed Chromatogr; 2018 Jan; 32(1):. PubMed ID: 28905405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
    Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A
    Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of selected beta-blockers.
    Ogrodowczyk M; Marciniec B
    Acta Pol Pharm; 2013; 70(5):779-86. PubMed ID: 24147355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of urine samples containing cardiovascular drugs by micellar liquid chromatography with fluorimetric detection.
    Carda-Broch S; Rapado-Martínez I; Esteve-Romero J; García-Alvarez-Coque MC
    J Chromatogr Sci; 1999 Apr; 37(4):93-102. PubMed ID: 10347884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iatrogenic dermatoses caused by beta-blocking drugs].
    Alinovi A; Branchetti A; Barella PA
    G Ital Dermatol Venereol; 1983; 118(6):341-8. PubMed ID: 6143722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.